pros in FA? those institution investors do not know much more than what we know, in the case of DNDN, everything is transparent, is published in FDA's website. Even ceo of biotech do not know the outcome of FDA decision, everybody is guessing on the same material. Did you see Adam Feuerstein from thestreet.com change his position back and forth, he is a pro working with Cramer together. Did you see all those newly created positions on DNDN's website? Even ency keep a 50 person sales team doing nothing for more than a year thinking they can get a FDA approval, but got defeated twice already, so no one knows other than FDA new commissioner.
Those guys shorting DNDN were not right, they were just lucky.
If it were not for biotech, it is easy to do FA for long term, like ebay, it may have a quarter miss, share price drop, but long term it will go up, a new company called loop is now doing a similar kind of business as ebay in commercial real estate. ADBL, a audio book downloading website, increasing membership quarter by quarter, exclusive relationship with publishers and APPLE. ...
Think again about FA, internet has united us, small investors together, we are not inferior anymore.